NetSpot Injection (Ga-68 Dotatate)

Base Notice:

Title:

NetSpot Injection (Ga-68 Dotatate)

Description(s):

20-002108

THIS IS A NOTICE OF INTENT, NOT A REQUEST FOR PROPOSAL. A SOLICITATION DOCUMENT WILL NOT BE ISSUED AND PROPOSALS WILL NOT BE REQUESTED.

The National Institutes of Health (NIH), Clinical Center  (CC), Health Information Management Department, intends to enter into a contract on a sole source basis, under the authority of 41 U.S.C. 253 (c) (1) and FAR 6.302-1(a) (2) (ii) and HHSAR 306.302-1 (a) (2) (ii), a contract to purchase NetSpot Injection (Ga-68 Dotatate)  from the Advanced Accelerator Applications USA, Inc..

If there are other sources able to supply the required material, they must respond by submitting a capability statement within 10 days of publication of this synopsis.

This notice of intent is not a request for competitive proposals. However, all proposals received prior to the closing date of this synopsis will be considered solely for the purpose of determining whether to conduct a competitive procurement.  A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Deliveries should be Hand Carried or sent via other mail or package Delivery Services. NO COLLECT CALLS OR FACSIMILE TRANSMISSIONS WILL BE ACCEPTED. RESPONDENTS MAY SUBMIT THEIR CAPABILITY STATEMENTS VIA E-MAIL TO THE POINT OF CONTACT LISTED IN THIS NOTICE OF INTENT SYNOPSIS.

The Clinical Center (CC) plans to procure, on a sole source basis, from the Advanced Accelerator Applications USA, Inc. 350 5th Ave Ste 6902 New York, NY, 10118-6902.

This acquisition will be processed under FAR Part 12 - Acquisition for Commercial Items and will be made pursuant to the authority in FAR 13.106-1(b)(2) and 13.501-(a)(1) to use simplified procedures for commercial acquisitions.  The North American Industry Classification System Code is 325412 and the business size standard of 1250.  Only one award will be made as a result of this solicitation. This will be a firm fixed price type contract.

To the maximum extent possible, please submit non-proprietary information. Any proprietary information submitted should be identified as such and will be properly protected from disclosure.

Interested Offerors should submit their capability statement not exceeding twenty (20) pages in length, excluding standard brochures. SUBMISSIONS ARE DUE no later than 9:00 a.m., Eastern Time, December 30, 2019. The capabilities response shall be e-mailed to: Michael.falzone@nih.gov .

All information received in response to this notice that is marked Proprietary will be handled accordingly.  Information provided in response to this notice will be used to assess alternatives available for determining how to proceed in the acquisition process. This notice is part of Government Market Research, a continuous process for obtaining the latest information on the commercial status of the industry with respect to their current and near-term abilities.  The information provided herein is subject to change and in no way binds the Government to solicit for or award a competitive contract.

The NIH/CC will use the information submitted in response to this notice at its discretion and will not provide comments to any submission; however, the content of any responses to this notice may be reflected in subsequent solicitation. NIH/CC/OPC reserves the right to contact any respondent to this notice for the sole purpose of enhancing NIH/CC/OPC 's understanding of the notice submission.

This announcement is Government market research, and may result in revisions in both its requirements and its acquisition strategy based on industry responses.

It is emphasized that this is a notice for planning and information purposes only and is not be construed as a commitment by the government to enter into a contractual agreement, nor will the government pay for information solicited.

Responses to this Notice of Intent shall be submitted before the closing date and time to the attention of the Contract Specialist listed below.

Primary Point of Contact:

Michael Falzone,

Contract Specialist

michael.falzone@nih.gov

Phone: 301 594 3886

Contracting Office Address:

6707 Democracy Blvd, Suite 106, MSC 5480
Bethesda, Maryland 20892-5480

Place of Contract Performance:

NIH Clinical Center, Building 10

10 Center Drive
Bethesda, Maryland 20892
United States